Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Self-Reliant Initiatives through Joint Action (SRIJAN) Vacancy of Accounts Profes…
INDIAN INSTITUTE OF MANAGEMENT INDORE IIM Indore seeks to be a contextually-rel…
Team Leads Reliance Foundation Location: Mumbai, Maharashtra Apply by: 11 Oct 2012…